Galectin-9 has demonstrated efficacy in a Dermatophagoides farinae allergen-induced asthma model by suppressing the expression of IL5, IL13, CCL11, CCL17, reducing eosinophilia, and pulmonary hyperresponsiveness [63]. The gene discussed is CCL17; the disease is asthma.